Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • The WHO recommends that all persons living with HIV be offered lifelong ART regardless of clinical stage or CD4+ cell count, with priority given to those with CD4+ cell counts ≤ 350 cells/mm3 and those with advanced HIV clinical disease (Management Guidelines)[WHO ART]
  • Regardless of CD4+ cell count or HIV clinical stage, ART is recommended for the following HIV-positive persons[WHO ART]:
    • Those with active TB disease

Action required

Keywords: Adherence, Initial Antiretroviral Therapy, Resource-Limited Settings, Special Populations, Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.